Open access
Open access
Powered by Google Translator Translator

Psychiatry

Cohort Study | Association between antiepileptic drugs and incident Parkinson disease

3 Feb, 2023 | 13:51h | UTC

Association Between Antiepileptic Drugs and Incident Parkinson Disease in the UK Biobank – JAMA Neurology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


M-A | Depressive symptoms in individuals with persistent postconcussion symptoms

3 Feb, 2023 | 13:48h | UTC

Depressive Symptoms in Individuals With Persistent Postconcussion Symptoms: A Systematic Review and Meta-Analysis – JAMA Network Open

Commentary: Significant Link Seen for Persistent Postconcussion Symptoms, Depression – HealthDay

 

Commentary on Twitter

 


Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews

2 Feb, 2023 | 15:05h | UTC

Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews – The BMJ

Editorial: Rethinking use of medicines for chronic pain – The BMJ

News Release: Antidepressants use for chronic pain on the rise, but are they effective? – University of Sidney

 

Commentary from the author on Twitter (thread – click for more)

 


Cohort Study | Association of treatment-resistant depression with patient outcomes and health care resource utilization

2 Feb, 2023 | 14:47h | UTC

Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study – JAMA Psychiatry

News Release: Patients with treatment resistant depression at higher risk of early death – Karolinska Institutet

Commentaries:

Treatment-Resistant Depression Associated With High Mortality, Lost Work Days, Health Care Use – Psychiatric News Alert

Treatment-Resistant Depression Common and Costly – HealthDay

 


Phase 2 RCT | Lysergic acid diethylamide–assisted therapy in patients with anxiety with and without a life-threatening illness

2 Feb, 2023 | 14:45h | UTC

Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study – Biological Psychiatry

Commentary: LSD-assisted therapy induces rapid and lasting reductions in anxiety and depression symptoms, according to new research – PsyPost

 


Placebo and nocebo effects: from observation to harnessing and clinical application

2 Feb, 2023 | 14:38h | UTC

Placebo and nocebo effects: from observation to harnessing and clinical application – Translational Psychiatry

 


Cohort Study | Associations between infant screen use, electroencephalography markers, and cognitive outcomes

1 Feb, 2023 | 13:34h | UTC

Associations Between Infant Screen Use, Electroencephalography Markers, and Cognitive Outcomes – JAMA Pediatrics

Commentaries:

Infant Screen Use Linked to Alterations in Cortical EEG Before Age 2 – HealthDay

Your child’s academic success may start with their screen time as infants, study says – CNN

 


Review | Safety and effectiveness of NMDA receptor antagonists for depression

1 Feb, 2023 | 13:05h | UTC

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review – Pharmacology

 


A new study provides insights into the emotional ‘blunting’ caused by common antidepressants

30 Jan, 2023 | 01:05h | UTC

Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study – Neuropsychopharmacology

News Release: Scientists explain emotional ‘blunting’ caused by common antidepressants – University of Cambridge

Commentary from the authors: Emotional ‘blunting’ and antidepressants – new research suggests why this is happening – The Conversation

 

Commentary on Twitter

 


Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations

26 Jan, 2023 | 12:55h | UTC

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations – Archives of Public Health

 


Cohort Study | Alcohol-related problems before and after metabolic and bariatric surgery in adolescents

26 Jan, 2023 | 12:01h | UTC

A Prospective Cohort of Alcohol use and Alcohol-related Problems Before and After Metabolic and Bariatric Surgery in Adolescents – Annals of Surgery (link to abstract – $ for full-text)

News Release: Problems with Alcohol Increase After Weight-Loss Surgery in Adolescence – Ann & Robert H. Lurie Children’s Hospital of Chicago

Related Study: Association Between Bariatric Surgery and Alcohol Use–Related Hospitalization and All-Cause Mortality in a Veterans Affairs Cohort – JAMA Surgery (link to abstract – $ for full-text)

 


ACP Guideline | Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder

24 Jan, 2023 | 14:41h | UTC

Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians – Annals of Internal Medicine

See also:

Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians – Annals of Internal Medicine

Cost-Effectiveness of First- and Second-Step Treatment Strategies for Major Depressive Disorder: A Rapid Review – Annals of Internal Medicine

Values and Preferences of Patients With Depressive Disorders Regarding Pharmacologic and Nonpharmacologic Treatments: A Rapid Review – Annals of Internal Medicine

Annals Video Summary – Nonpharmacologic and Pharmacologic Treatments for Adult Patients With Major Depressive Disorder – Annals of Internal Medicine

 


Cohort Study | The temporal relationship between severe mental illness diagnosis and chronic physical comorbidity

24 Jan, 2023 | 14:31h | UTC

The temporal relationship between severe mental illness diagnosis and chronic physical comorbidity: a UK primary care cohort study of disease burden over 10 years – The Lancet Psychiatry

Commentary: Severe mental illness and comorbid chronic physical illness: the clock’s ticking – The Mental Elf

 

Commentary on Twitter

 


M-A | Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics

24 Jan, 2023 | 14:23h | UTC

Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials – World Psychiatry

Commentary: Metabolic Side Effects of Antipsychotics Vary, Meta-Analysis Finds – Psychiatric News Alert

 


Cohort Study | Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis

24 Jan, 2023 | 14:14h | UTC

Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis – Clinical Gastroenterology and Hepatology

News Release: Scientists provide evidence of the positive effects of alcohol abstinence in advanced liver cirrhosis – University of Viena / News Medical

 


RCT | Telehealth treatment of behavior problems in young children with developmental delay

20 Jan, 2023 | 14:38h | UTC

Telehealth Treatment of Behavior Problems in Young Children With Developmental Delay: A Randomized Clinical Trial – JAMA Pediatrics (link to abstract – $ for full-text)

Commentaries:

Telehealth parent-child interaction therapy improved behavior in children with developmental delay – MDedge

Telehealth Parent-Child Interaction Therapy Aids Child Behavior – HealthDay

 

Commentary on Twitter

 


Review | An FP’s guide to identifying—and treating—postpartum depression

19 Jan, 2023 | 13:56h | UTC

An FP’s guide to identifying—and treating—postpartum depression – Journal of Family Practice

 


Cohort Study | Safety and effects of buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder

18 Jan, 2023 | 14:10h | UTC

Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder – Acta Obstetricia et Gynecologica Scandinavica

Commentary: Buprenorphine-Naloxone Appears Safe for Maternal Opioid Use Disorder – HealthDay

 


State of the Art Review | Telemental health for clinical assessment and treatment

17 Jan, 2023 | 13:29h | UTC

Telemental health for clinical assessment and treatment – The BMJ

 

Commentary on Twitter

 


RCT | Effects of breathwork exercises vs. mindfulness meditation in mood and anxiety

17 Jan, 2023 | 13:25h | UTC

Brief structured respiration practices enhance mood and reduce physiological arousal – Cell Reports Medicine

Commentaries:

A Simple, 5-Minute Breathing Technique Is a Powerful Tool to Reduce Anxiety – Science Alert

Study shows cyclic breathing technique more effective in reducing stress than mindfulness meditation – MedicalXpress

 

Commentary on Twitter

 


M-A | Effect of breathwork on stress and mental health

15 Jan, 2023 | 20:28h | UTC

Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials – Scientific Reports

Commentary: Review and meta-analysis suggests breathwork may be effective for improving stress and mental health – News Medical

 

Commentary on Twitter

 


Cohort Study | Trends in antipsychotic prescribing to children and adolescents in England

15 Jan, 2023 | 20:26h | UTC

Trends in antipsychotic prescribing to children and adolescents in England: cohort study using 2000–19 primary care data – The Lancet Psychiatry

News Release: Researchers reveal worrying rise in antipsychotic prescriptions for children and young people – University of Manchester

 

Commentary on Twitter

 


SR | Baclofen for alcohol use disorder

15 Jan, 2023 | 20:11h | UTC

Baclofen for alcohol use disorder – Cochrane Library

Summary: Baclofen for alcohol use disorder – Cochrane Library

 


RCT | Ecopipam for Tourette Syndrome

15 Jan, 2023 | 20:09h | UTC

Ecopipam for Tourette Syndrome: A Randomized Trial – Pediatrics

Commentary: Ecopipam May Reduce Tics in Children With Tourette Syndrome – Psychiatric News Alert

 

Commentary on Twitter

 


Retrospective Study | Most patients with long Covid developed after mild infection get better within a year

13 Jan, 2023 | 13:42h | UTC

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study – The BMJ

News Release: Most long COVID effects resolve within a year after mild infection, finds study- British Medical Journal

Commentary: Long COVID After Mild Infection? It Fades Within a Year – HealthDay

 


Stay Updated in Your Specialty

No spam, just news.